These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8608487)

  • 41. Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas.
    Stege R; Grande M; Carlström K; Tribukait B; Pousette A
    Clin Cancer Res; 2000 Jan; 6(1):160-5. PubMed ID: 10656445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.
    Satoh T; Yang G; Egawa S; Addai J; Frolov A; Kuwao S; Timme TL; Baba S; Thompson TC
    Cancer; 2003 Mar; 97(5):1225-33. PubMed ID: 12599229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
    Yu DS; Hsieh DS; Chen HI; Chang SY
    J Urol; 2001 Sep; 166(3):871-5. PubMed ID: 11490236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
    Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical significance of pulmonary metastases in stage D2 prostate cancer patients.
    Nakamachi H; Suzuki H; Akakura K; Imamoto T; Ueda T; Ishihara M; Furuya Y; Ichikawa T; Igarashi T; Ito H
    Prostate Cancer Prostatic Dis; 2002; 5(2):159-63. PubMed ID: 12497007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic value of the HNK-1 (Leu-7) antigen in prostatic cancer--an immunohistochemical study.
    Liu XH; Yoshiki T; Kokuho M; Okada Y; Tomoyoshi T; Higuchi K
    Hinyokika Kiyo; 1993 May; 39(5):439-44. PubMed ID: 7686713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The prognostic significance of determining androgen receptors in prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Svetozarskiĭ NL; Matveev BP; Gorilovskiĭ LM; Makarova GV; Bukharkin BV; Shakhov EV; Kliuchikhin OZ
    Urol Nefrol (Mosk); 1993; (1):7-10. PubMed ID: 7941132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy.
    Prins GS; Sklarew RJ; Pertschuk LP
    J Urol; 1998 Mar; 159(3):641-9. PubMed ID: 9474117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inability of cytoplasmic or nuclear androgen receptor content or distribution to distinguish benign from carcinomatous human prostate.
    Shain SA; Gorelic LS; Klipper RW; Ramzy I; Novicki DE; Radwin HM; Lamm DL
    Cancer Res; 1983 Aug; 43(8):3691-5. PubMed ID: 6861139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry.
    de Winter JA; Trapman J; Brinkmann AO; Boersma WJ; Mulder E; Schroeder FH; Claassen E; van der Kwast TH
    J Pathol; 1990 Apr; 160(4):329-32. PubMed ID: 2193135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical study of HNK-1 (Leu-7) antigen in prostate cancer and its clinical significance.
    Liu X; Zhan B; Tomoyoshi T; Masanori T
    Chin Med J (Engl); 1995 Jul; 108(7):516-21. PubMed ID: 7555270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone receptors in human prostate cancer.
    Blankenstein MA; Bolt-de Vries J; van Aubel OG; van Steenbrugge GJ
    Scand J Urol Nephrol Suppl; 1988; 107():39-45. PubMed ID: 3287596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic value of pretreatment expression of androgen receptor and bcl-2 in hormonally treated prostate cancer patients.
    Noordzij MA; Bogdanowicz JF; van Krimpen C; van der Kwast TH; van Steenbrugge GJ
    J Urol; 1997 Nov; 158(5):1880-4; discussion 1884-5. PubMed ID: 9334622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen receptor immunohistochemistry on paraffin-embedded tissue.
    Loda M; Fogt F; French FS; Posner M; Cukor B; Aretz HT; Alsaigh N
    Mod Pathol; 1994 Apr; 7(3):388-91. PubMed ID: 8058713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade.
    Zhou R; Hammond EH; Sause WT; Rubin P; Emami B; Pilepich MV; Asbell SD; Parker DL
    Mod Pathol; 1994 May; 7(4):440-8. PubMed ID: 7520585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].
    Bassalyk LS; Petrova AS; Ermilova VD; Sokolova VK; Kushlinskiĭ NE
    Arkh Patol; 1983; 45(2):23-8. PubMed ID: 6847409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
    Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
    [No Abstract]   [Full Text] [Related]  

  • 59. Methods for the determination of androgen receptor content in human prostatic tissue.
    Trachtenberg J; Hicks LL; Walsh PC
    Invest Urol; 1981 Mar; 18(5):349-54. PubMed ID: 7203958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy.
    Rauen KA; Sudilovsky D; Le JL; Chew KL; Hann B; Weinberg V; Schmitt LD; McCormick F
    Cancer Res; 2002 Jul; 62(13):3812-8. PubMed ID: 12097294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.